Avadel Pharmaceuticals's total assets for Q3 2025 were $199.45M, an increase of 6.57% from the previous quarter. AVDL total liabilities were $101.22M for the fiscal quarter, a 4.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.